Why are there gaps in our management of those with high cardiovascular risk?

Fiona Doolan-Noble1, Jocelyn Tracey, Stewart Mann

  • 1Department of Medicine, University of Otago, Wellington, New Zealand. Fiona@xtra.co.nz

Insights

Health professionals identified patient factors, provider issues, and systemic challenges as barriers to managing high cardiovascular risk patients in New Zealand primary health care (PHC). Addressing these requires a coordinated PHC sector refocus with policy support.

Area of Science:

  • Cardiovascular disease prevention
  • Primary health care research
  • Health services management

Background:

  • International studies reveal management gaps for high cardiovascular (CV) risk individuals.
  • This study investigates health professional perspectives on barriers and facilitators in CV risk management within New Zealand's primary health care (PHC) system.

Purpose of the Study:

  • To explore health professional views on barriers and facilitators to optimal management of high CV risk patients.
  • To identify key factors influencing cardiovascular risk management in the primary health care setting.

Main Methods:

  • Qualitative study utilizing focus groups.
  • General inductive approach for text data analysis of primary health care (PHC) barriers and facilitators.

Main Results:

  • Key themes emerged: patient factors (circumstances, perceptions), primary health care providers (communication, values), general practice (planning, workload, roles), and the health system (funding, leadership).
  • Interrelated themes highlight the complexity of managing high CV risk patients.

Conclusions:

  • Factors influencing high CV risk management in New Zealand's PHC sector were identified.
  • General practice is crucial for preventive care, necessitating a sector refocus supported by policymakers, health boards, and practitioners.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...